Quantigen
UEI: VVJZEQX9GN78
• CAGE: 6BWV3
Overview
Parent Awardee
Federal Capability Statement
Quantigen specializes in qPCR assay development and validation in support of pre-clinical and clinical studies. Quantigen is expert at small biomarker sample preparation and assay development. We also offer PGx diagnostic testing.
Keywords
CDNA, CLIA, Clinical Trial, ddPCR, Digital PCR, DNA, GCP, gDNA, Gene Expression, Genomic DNA, Genotyping, GLP, Haplotype, Micro RNA, microRNA, miRNA, mRNA, nucleic acid, PCR, PGx, Pharmacogenomics, qPCR, Real Time PCR, RNA, Taqman
Website
Headquarters
Fishers, IN
United States
United States
Most Recent Award
July 3, 2019
Calculating
Federal contract recipient
QUANTIGEN, LLC
(UEI VVJZEQX9GN78, CAGE 6BWV3)
is headquartered in Fishers IN.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The tax-exempt corporation
was founded in May 2007 and
federally registered in
March 2011.
Federal Award Analysis
Quantigen federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
QUANTIGEN, LLC
UEI
VVJZEQX9GN78
CAGE Code
6BWV3
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 22, 2007
Initial Registration
March 24, 2011
Last Registration
Oct. 28, 2024
Registration Activation
Oct. 28, 2024
Registration Expiration
Oct. 22, 2025
Fiscal Year End
December 31
Reported Entity Types
Non-Profit Organization
State of Incorporation
IN
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No